Jordi Gratacós
Universitat Autònoma de Barcelona(ES)Corporació Sanitària Parc Taulí(ES)Hospital de Sabadell(ES)Institute of Research and Innovation Parc Tauli(ES)Deleted Institution
Publications by Year
Research Areas
Spondyloarthritis Studies and Treatments, Rheumatoid Arthritis Research and Therapies, Psoriasis: Treatment and Pathogenesis, Autoimmune and Inflammatory Disorders Research, Osteoarthritis Treatment and Mechanisms
Most-Cited Works
- → Ixekizumab for the treatment of patients with active psoriatic arthritis and an inadequate response to tumour necrosis factor inhibitors: results from the 24-week randomised, double-blind, placebo-controlled period of the SPIRIT-P2 phase 3 trial(2017)395 cited
- → SERUM CYTOKINES (IL-6, TNF-α, IL-1β AND IFN-γ) IN ANKYLOSING SPONDYLITIS: A CLOSE CORRELATION BETWEEN SERUM IL-6 AND DISEASE ACTIVITY AND SEVERITY(1994)335 cited
- → Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial(2020)278 cited
- → Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report(2007)190 cited
- → Efficacy and safety of guselkumab in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study(2018)181 cited